Ultragenyx Pharmaceutical Inc
Closed
SectorHealthcare
24.38 1.41
Overview
Share price change
24h
Min
23.92
Max
24.75
Income | -56M -185M |
|---|---|
Sales | -71M 136M |
EPS | -1.54 |
Profit margin | -136.029 |
Employees | 1,371 |
EBITDA | -56M -161M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +116.31% upside |
Next Earnings | 4 Aug 2026 |
|---|
Market Cap | -313M 2.1B |
|---|---|
Previous open | 22.97 |
Previous close | 24.38 |
News Sentiment
By Acuity
50%
50%
156 / 344 Healthcare
Ultragenyx Pharmaceutical Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Ultragenyx Pharmaceutical Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 51.87 USD 116.31%
High 96 USD
Low 25 USD
Based on 16 Wall Street analysts offering 12 month price targets forUltragenyx Pharmaceutical Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$